Physician profile
Henry Chou
NPI 1821387374
$3,099.65
in general payments reported to CMS, 2019-2025
12 companies · $21.58 in 2025
The $21.58 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $212 · 2021: $1,634 · 2022: $274 · 2023: $325 · 2024: $401 · 2025: $21.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $747.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,590.26 | 2021-2024 | Indigo System |
| Boston Scientific Corporation | $599.11 | 2019-2024 | Ekosonic, Embold Fibered |
| Medtronic, INC. | $426.84 | 2021-2023 | Hawkone, Concertotm |
| Kestra Medical Technology Services, INC. | $162.78 | 2023 | Assure Wcd |
| Stryker Corporation | $79.67 | 2024-2025 | Augment Injectable, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic Vascular, INC. | $75.24 | 2019-2020 | |
| Abbott Laboratories | $57.90 | 2021-2023 | Diamondback Peripheral |
| Inari Medical, INC. | $33.42 | 2019-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiva Medical, INC. | $26.47 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $16.40 | 2019 | |
| Bard Peripheral Vascular, INC. | $16.10 | 2023 | Venovo |
| Avanos Medical | $15.46 | 2023 | Mic-Key |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Chou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.